Overview
CardioMET is an observational, multicenter, real-life registry, intending to collect data on patients with Type 2 Diabetes Mellitus, attending internal medicine and cardiology outpatient clinics. The aim of the registry is to characterize the cardiovascular risk profile and pharmacological management of Type 2 Diabetes Mellitus in Italy, in accordance with current ESC and AHA guidelines for primary and secondary prevention of CV disease.
Eligibility
Inclusion Criteria:
- Age ≥ 18 years;
- Diagnosis of type 2 diabetes mellitus (T2DM);
- Ability to understand the study procedures and provide written informed consent.
Exclusion Criteria:
- Known or suspected liver disease;
- Patients with type 1 diabetes mellitus;
- Cardiac surgery or percutaneous coronary revascularization scheduled within the next 3 months;
- Patients with acute inflammatory or infectious diseases during the previous 3 months;
- Patients with chronic inflammatory, immune, or infectious diseases;
- Patients with ongoing malignant neoplasms;
- History of alcohol, drug, or medication abuse;
- Clinically significant hematological disorders;
- Systemic steroid treatment within the last 6 months;
- Acute-phase metabolic disorders;
- Any condition that may put the patient at risk by participating in the study.